Speech-Language Pathologists in Newburgh, IN Accepting Medicare

29 Speech-Language Pathologists found. Showing 21 - 29

Whitney Nicole Richardson, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4655 Rosebud Ln, Newburgh, IN 47630 Phone: 812-213-8031    Fax: 317-520-8200

Adison Denu, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4655 Rosebud Ln, Newburgh, IN 47630 Phone: 812-213-8031    Fax: 317-520-8200

Mrs. Tessie A Turpen, MA CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4255 Medwel Dr, Newburgh, IN 47630 Phone: 812-853-2993    Fax: 812-853-8845

Justine Marie Schnur, MS,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9800 Outer Lincoln Ave, Newburgh, IN 47630 Phone: 812-887-5201

Sarah Claybon, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4199 Gateway Blvd Ste 3800, Newburgh, IN 47630 Phone: 812-842-2820

Emily Lentz Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4011 Gateway Blvd, Newburgh, IN 47630 Phone: 812-842-3770

Blair Case, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9355 Warrick Trl, Newburgh, IN 47630 Phone: 812-476-9983

Nicole Elizabeth Vickers, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4011 Gateway Blvd, Newburgh, IN 47630 Phone: 812-842-3770    Fax: 812-842-3771

Donna Gail Coleman, M.S., SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7600 Michael Ln, Newburgh, IN 47630 Phone: 360-359-8544

News Archive

Bortezomib reduces inflammation and promotes bone healing in arthritis models

A new study by Greek researchers suggests that the biologic drug bortezomib (Velcade), a proteasome inhibitor used to treat multiple myeloma (bone marrow cancer), may represent a promising treatment for rheumatoid arthritis (RA). In this study, bortezomib displayed favorable effects in an animal model of inflammatory arthritis that mimics RA, in reducing disease severity and inflammation, and promoting bone healing. Full findings of this study are published in the November issue of Arthritis & Rheumatism, a journal of the American College of Rheumatology (ACR).

USPTO issues patent for Rosetta Genomics' human microRNA miR-193b

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, announced today that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 7,592,441 to Rosetta Genomics. The patent relates to human microRNA miR-193b, as well as to complementary probes and vectors. This is the third patent issued to Rosetta Genomics by the USPTO.

Simple blood test useful for excluding pulmonary embolism among hospitalized COVID-19 patients

A screening blood test originally validated in seriously ill patients without COVID-19 is still clinically useful for ruling out pulmonary embolism in patients hospitalized with the coronavirus, a University of South Florida Health (USF Health) Morsani College of Medicine research team reports.

Emerging oral atypical antipsychotics to compete in increasingly crowded schizophrenia drug market

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in the world's major pharmaceutical markets, emerging oral atypical antipsychotics will compete against each other and against established drugs for the same niche patient population in the treatment of schizophrenia.

Wildfire smoke drives people in low-vaccinated areas indoors, raising outbreak fears

Missoula's new downtown library was teeming with people who might typically spend a Saturday afternoon hiking, biking or otherwise making the most of Montana's abundant outdoor recreation. One look at the soupy haze blanketing the city and it was clear why.

Read more Medical News

› Verified 5 days ago

• 1
• 2(current)